Database of Pelvic Inflammatory Disease

Inflammatory Pelvic Disease Clinical Trial

Official title:

Prospective Data Collection of Patients With Pelvic Inflammatory Disease

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02567812
• Other study ID #: 2015-04-009
• Status: Recruiting
• Start date: October 2015
• Est. completion date: September 2024

Study information

• Verified date: April 2019
• Source: Kangbuk Samsung Hospital
• Contact: Taejong Song, MD PhD
• Phone: +82-10-4035-8405
• Email: taejong.song[@]gmail.com
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The aim of this prospective study is to collect data on in-patients with pelvic inflammatory disease(PID) at Kangbuk Samsung Hospital.

Description:

The aim of this prospective study is to collect data on in-patients with pelvic inflammatory disease(PID) at Kangbuk Samsung Hospital. If patients agree to participate in this clinical trial, patient's data (such as age, body mass index, preoperative findings, laboratory findings, radiologic findings, operative findings, pathologic findings, postoperative findings) will be collected in a research database. The research database will be updated, every 6 month, to include data on patient's disease outcome and follow-up care. Although most data will be collected form the medical record, patient may agin be contacted so that researchers can collection some data if it is not in the medical record.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 200
• Est. completion date: September 2024
• Est. primary completion date: September 2024
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 19 Years to 80 Years

Eligibility

Inclusion Criteria:

• All in-patient with PID who diagnosed at Kangbuk Samsung Hospital

Exclusion Criteria:

• Secondary PID caused by other surgical problem or disease

• An inability to fill-up the informed consent

Related Conditions & MeSH terms

• Inflammatory Pelvic Disease
• Pelvic Inflammatory Disease

Locations

Country	Name	City	State
Korea, Republic of	Kangbuk Samsung Hospital	Seoul

Sponsors (1)

Lead Sponsor	Collaborator
Kangbuk Samsung Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	PID database	number of participants with pelvic inflammatory disease	10 years